STOCKS TELEGRAPH

Author: Shimrez Hyder

  • CohBar Inc. (CWBR) Stock Plummets Following Announcement of Underwritten Public Offering

    CohBar Inc. (CWBR) stock prices were down by 1.10% as of the market closing on October 27th, 2021. This brought the price per share down to USD$0.90. Subsequent premarket fluctuations saw the stock plummet by 26.68%, bringing it down to USD$1.61.

    Underwritten Public Offering

    October 27th, 2021 saw CWBR stock announce its proposed underwritten public offering of shares of its common stock and accompanying warrants to purchase common stock. Each of the company’s warrants will be exercisable for five years from the date the offering is closed. The stocks and warrants for stocks being sold as a part of the offering will all be offered by the company, being subject to market conditions. The closing of the offering is not guaranteed, nor is its finalized size or terms.

    Allocation of CWBR Stock’s Funds

    Net proceeds generated by CWBR stock’s offering will be allocated towards general corporate purposes. The proceeds raised will be used in conjunction with the company’s existing cash resources to fund the preclinical and clinical development of its peptides. Together, these resources will also be used to increase working capital, as well as to cover operating expenses and capital expenditures.

    CB4211 Results Presentation

    October 13th, 2021 saw CWBR stock announce data from its CB4211 Phase 1a/1b clinical study having been selected for presentation. The presentation will take place during the poster session at The American Association for the Study of Liver Diseases (AASLD) Annual Meeting. The meeting will be held virtually from November 12th to the 15th of 2021.

    CWBR Stock’s Continued Development

    The presentation will discuss additional details from the Phase 1a/1b clinical study of CB4211 in obese subjects with nonalcoholic fatty liver disease (NAFLD). This is a follow-up of the company’s announcement of positive topline data from the trial from August 2021. These results included statistically significant reductions in ALT, AST, and glucose, as compared to placebo after a CB4211 treatment period of four weeks. The treatment is currently being developed as a therapy for the treatment of nonalcoholic steatohepatitis and obesity.

    Future Outlook for CWBR Stock

    CWBR stock is poised to capitalize on the opportunities afforded to it in light of the development of its CB4211. The company is keen to take steps to continue its trajectory of success in a bid to usher in unprecedented growth. Current and potential investors are hopeful that management will be able to effectively leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value over the long term.

  • Evelo Biosciences Inc. (EVLO) Stock Prices Trend Lower Despite Positive Data from Phase 2 Study of EDP1815

    Evelo Biosciences Inc. (EVLO) stock prices were down by 2.95% as of the market closing on September 24th 2021. This brought the price per share down to USD$7.25 at the end of the trading day. Subsequent premarket fluctuations have seen the stock dip by 0.83%, bringing it down to USD$7.14.

    Positive Topline Data

    September 27th, 2021 saw EVLO stock announce positive data from its Phase 2 study. The study was designed to evaluate EDP1815 versus placebo for the treatment of mild and moderate psoriasis. The study exhibited a statistically significant reduction in the Psoriasis Area and Severity Index (PASI) score. The score is measured by the proportion of patients achieving at least 50% improvement in PASI from baseline at the week 16 timepoint. EDP1815 is currently being developed as an investigational oral biologic for the treatment of a broad range of inflammatory diseases, including clinical programs in psoriasis, atopic dermatitis, and Covid-19.

    Scope of EVLO Stock’s EDP1815

    The clinical results represent a significant advancement for patients who live with inflammatory disease. Being the first of its kind, the Phase 2 study demonstrates the utility of harnessing small intestinal axis to make a clinical impact on patients. These patients are administered the oral product candidate that is backed by safety and tolerability data that is better than the placebo. On the basis of the positive data, EVLO stock intends to advance EDP1815 towards registration studies in psoriasis. The company is looking forward to discussing their next steps with health and regulatory authorities. The milestone brings the company closer to realizing its vision of transforming healthcare. This will be facilitated by developing broadly acting oral, safe, effective, and affordable medicines. As a result, affordable medicines will be provided to address the unmet needs of hundreds of millions of patients around the world who live with inflammatory disease.

    Measuring Success

    PASI scored from the Phase 2 study were assessed by both mean changes from baseline and responder rates. The primary endpoint was the mean percentage change in PASI between treatment and placebo, having been prespecified as a Bayesian analysis. The Bayesian approach provides an estimate of the probability that EDP1815 is superior to placebo.

    Future Outlook for EVLO Stock

    The company has reported a promising quarter, consolidated by the success of its Phase 2 study for EDP1815. EVLO stock is poised to push for the accelerated commercialization and proliferation of the treatment. Current and potential investors are hopeful that management will be able to leverage the resources at its disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Flux Power Holdings Inc. (FLUX) Stock Plummets Despite Promising Q4 2021 Financials

    Flux Power Holdings Inc. (FLUX) stock prices plummeted by 20.35% some time after market trading commenced on September 23, 2021. This brought the price per share down to USD45.99 early on in the trading day.

    FLUX Stock Listed on Nasdaq

    The company reported being uplisted on the Nasdaq Capital Market under the ticker symbol FLUX. Before being uplisted, the company’s common stock was listed on the OTCQB. Following the uplisting, FLUX stock reported having raised USD$12.4 million in equity capital. This facilitated an increase in its shareholder base and included institutional investors. The company managed to convert USD$5.2 million of debt to equity, resulting in an elimination of all of its debt. This will serve to strengthen the company’s balance sheet and capital structure.

    Quarterly Developments

    FLUX stock launched the next generation of lithium-ion battery pack for end riders and center riders. This has been met with positive feedback from customers with substantial orders. Deliveries have also been initiated to the world’s largest meat processor, as well as two other major customers. These customers are a paper products and chemicals manufacturer and a packaging manufacturer. The onset of the global coronavirus pandemic disrupted deliveries to a global airline. The company recently announced the resumption of these deliveries.

    FLUX Stock’s Revenue Reports

    The fourth quarter of fiscal 2021 saw the company report revenues in the amount of USD$8.3 million. This is a 33% year-over-year increase from the USD$6.3 million reported in the fourth quarter of fiscal 2020. The yearly difference was largely driven by sales of larger LiFT Packs. Fiscal Q4 of 2021 represents the 12th consecutive quarter of year-over-year revenue increases.

    Gross Profit Reports

    Gross profit for the fourth fiscal quarter of 2021 was reported by FLUX stock in the amount of USD$1.8 million. This is comparable to the USD$1.1 million gross profit reported for the fourth quarter of fiscal 2021. The year-over-year increase was largely attributable to the higher sales volumes in the 2021 quarter. further consolidating the increase was the company’s revenue growth and gross margin improvement program.

    Future Outlook for FLUX Stock

    The company reported a promising quarter, as evidenced by the strength of its financial reports. FLUX stock is keen to capitalize on the momentum generated over the last several quarters. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Inovio Pharmaceuticals Inc. (INO) Stock Exhibits Minor Volatility Following Receiving of Regulatory Approval

    Inovio Pharmaceuticals Inc. (INO) stock prices were down by 0.89% as of the market closing on September 22nd, 2021. This brought the price per share down to USD$7.79 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 1.16%, bringing it up to USD$7.88.

    INO Stock Gains Approval

    September 22nd, 2021 announced having received authorization from COFEPRIS to conduct a clinical trial in Mexico. The approval will allow the commencement of the Phase 3 segment of INO stock’s global Phase 2/3 trial, INNOVATE. The trial is for the company’s DNA vaccine candidate for Covid-19, INO-4800. The company is collaborating with its partner Advaccine Biopharmaceuticals Suzhou Co., Ltd. on the INNOVATE Phase 3 segment in multiple countries. The company recently announced having been granted regulatory authorization to commence Phase 3 clinical trial in Brazil and the Philippines. Further authorization to conduct trials in other countries is currently being pursued.

    Phase 3 INNOVATE Trial

    The global Phase 3 segment of the INNOVATE trial is designed to evaluate the efficacy of INO-4800. The treatment will consist of a two dose regimen, with each dose amounting to 2 mg. the doses will be administered one month apart, in a 2 to 1 randomization in men and non-pregnant women above the age of 17. The primary endpoint of the case-driven Phase 3 trial is virologically confirmed Covid-19.

    INO Stock Works with Authorities

    INO stock is keen to continue collaborating with health authorities and investigators in Mexico, Brazil, and the Philippines. These partnerships are set to advance the evaluation of INO-4800 as a solution in the ongoing global fight against the coronavirus pandemic. With millions of people around the world still remaining unvaccinated, the company is committed to supporting the international public health response.

    Scope of INO-4800

    Accordingly, INO stock is well positioned to evaluate the efficacy of INO-4800, which will prove to be a critical developmental milestone. The company is confident that its proprietary Covid-19 vaccine is uniquely suited to contribute to global efforts. This is on the basis of its strong safety and thermostability profile, ability to generate cross-reactive immune responses, and its potential to function in a primary series as well as a booster vaccine.

    Future Outlook for INO Stock

    With the world hurtling towards universal immunizations, INO stock is poised to capitalize on the burgeoning scope of opportunities. The company is keen to accelerate the development and proliferation of its INO-4800 treatment. Current and potential investors are confident that management will be able to effectively leverage the resources at their disposal. This is hoped to usher in significant and sustained increases in shareholder value.

  • Kroger Co. (KR) Stock Dips After Disclosure of Financial Reports for Q2 2021

    Kroger Co. (KR) Stock Dips After Disclosure of Financial Reports for Q2 2021

    Kroger Co. (KR) stock prices were down by 7.05% some time after market trading commenced on September 10th, 2021. This brought the price per share down to USD$42.88 early on in the trading day.

    KR Stock’s Strategic Focus

    KR stock’s strategic focus is on leading with fresh while accelerating with digital. This is hoped to continue to build momentum across the business. The seamless working of the company’s ecosystem was evidenced by the seamless shift of customers between channels. This resulted in a continuation of strong digital engagement. Trends indicate that customers are eating more food at home. This is driven by affordability, convenience, and health-consciousness, as compared to alternatives.

    Mitigating Effects of Pandemic

    The company’s associates have continued supporting their customers and communities through the challenges presented by the pandemic. This is facilitated by the delivery of a full, fresh, and friendly experience every day. KR stock is committed to its environmental, social, and governance strategy. It hopes that this will result in positive outcomes for both customers and the planet, with the creation of more resilient global systems. The company’s Zero Hunger | Zero Waste social and environmental impact plan drives the company’s aims.

    Gross Margin Reports

    Gross margin for the second quarter of fiscal 2021 came out to 21.4% of sales. The FIFO gross margin rate excluded fuel and was down 60 points as compared to the prior year quarter. the year over year decrease was largely driven by continued price investments. Further consolidating the yearly difference was higher shrink and supply chain costs. Sourcing benefits and growth in the alternative profit business partially offset the year over year decrease.

    Additional KR Stock Financials

    The LIFO charge for the second quarter of fiscal 2021 came out to USD$47 million. This is comparable to the USD$23 million reported in the prior year quarter. the year over year increase was largely driven by inflation in fresh categories. KR stock reported Operating, General, and Administrative rate was down by 76 points, excluding fuel and adjustment items. This reflects lower Covid-19 related costs, as well as the execution of cost savings initiatives.

    Future Outlook for KR Stock

    The company reported a promising quarter, as evidenced by its financial reports for Q2 2021. KR stock is poised to capitalize on the opportunities afforded to it as consumer trends continue during the persistent pandemic. Current and potential investors are hopeful that management will be able to usher in organic growth over the long term.

  • A-Mark Precious Metals Inc. (AMRK) Stock Surged Following Disclosure of Stellar Financial Reports for Q4 2021

    A-Mark Precious Metals Inc. (AMRK) Stock Surged Following Disclosure of Stellar Financial Reports for Q4 2021

    A-Mark Precious Metals Inc. (AMRK) stock prices surged by 14.30% some time after market trading commenced on September 10th, 2021. This brought the price per share up to USD$59.48 early on in the trading day.

    AMRK Stock’s Revenue Reports

    Revenues for the fourth quarter of fiscal 2021 were reported at USD$2.18 billion. This represents a 31% increase from the USD$1.67 billion reported in the prior year quarter. As compared to the quarter ended March 31st 2021, Q4 2021 reported revenues in the amount of USD$2.05 billion. The year over year and quarter over quarter increases were largely driven by an increase in sales. Specifically, the total amount of gold and silver ounces sold was up substantially. The increase was consolidated by the higher selling prices of gold and silver, while being partially offset by lower forward sales. Q4 2021 results included USD$603.8 million in revenue from AMRK stock’s acquisition of JMB.

    Gross Profit Breakdown

    Gross profits for the fourth quarter of fiscal 2021 came out to USD$87.1 million, the highest ever recorded for the company. This represented a 211% year over year increase from the USD$28 million reported for the quarter ended June 30th 2020. As compared to the USD$68.2 million in revenue reported for the quarter ended March 31st 2021, this is a 28% year over year increase. This year over year and quarter over quarter increase was largely attributable to higher gross profits earned by the Wholesale Sales and Ancillary Services and Direct-to-Consumer segments.

    SG&A Costs

    Selling, general, and administrative expenses were reported at USD$25 million for the fourth quarter of fiscal 2021. This is a 144% increase from the USD$10.2 million reported in the prior year quarter. this year over year increase was largely driven by USD$12.8 million in expenses incurred by the recently acquired JMB. USD$7.7 million of this total was attributable to amortization expense. Overall increases in consulting costs came out to USD$0.5 million, while compensation expense was reported at USD$0.3 million. Insurance costs were USD$0.7 million for the quarter. Overall, 51% of the total consolidated SG&A costs for the quarter were attributable to JMB.

    Future Outlook for AMRK Stock

    The company reported an encouraging quarter, as evidenced by the success of its financial reports for the Q4 2021. AMRK stock is poised to capitalize on the momentum generated over the course of fiscal 2021 into the start of fiscal 2022. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Vince Holding Corp. (VNCE) Stock Surged Following Immense Success of Financial Reports for Q2 2021

    Vince Holding Corp. (VNCE) Stock Surged Following Immense Success of Financial Reports for Q2 2021

    Vince Holding Corp. (VNCE) stock prices surged by 16.39% as of the market closing on September 10th, 2021. This brought the price per share up to USD$7.81 early on in the trading day.

    Net Sales Reports

    Total net sales for the second quarter of fiscal 2021 were reported in the amount of USD$78.7 million. This represents a 112.5% year-over-year increase from the USD$37 million reported for the prior-year quarter. Net loss for the 2021 quarter came out to USD$0.6 million, representing a net loss of USD$0.05 per share. This is comparable to the USD$15.1 million net loss reported in the prior-year quarter, which came out to a net loss of USD$1.28 per share.

    Gross Profit and Margin

    VNCE stock reported a gross profit in the amount of USD$35.4 million for the second quarter of fiscal 2021. This accounted for 45% of net sales for the quarter. The prior-year quarter saw the company report gross profit in the amount of USD$13.3 million, which came out to 36% of net sales. The year-over-year increase was largely attributable to channel mix, lower year-over-year adjustments to inventory reserves, and lower promotional activity in the direct-to-consumer channel.

    VNCE Stock’s SG&A Costs

    Selling, general, and administrative costs came out to USD$32.7 million for the second quarter of fiscal 2021. This represents 41.6% of sales for the quarter. These figures are comparable to the USD$27.3 million SG&A costs reported for Q2 2020, which represented 73.9% of net sales. The year-over-year increase was largely driven by higher payroll and compensation expenses, increased investments in marketing, and increase consulting and other third-party costs.

    VNCE Stock’s Capital

    The end of the second quarter of fiscal 2021 saw VNCE stock report total borrowings in the amount of USD$87.3 million. In addition to these debt agreements, the company also reported USD$34.4 million of surplus availability under its revolving credit facility. September 7th, 2021 saw the company enter into a new USD$35 million senior secured term loan credit facility

    Future Outlook for VNCE Stock

    VNCE stock reported a promising quarter, as evidenced by the strength of its financial reports for Q2 2021. The company plans to continue allocating resources towards maintaining the momentum generated over H1 2021. Current and potential investors are hopeful that management will be able to facilitate significant and sustained increases in shareholder value over the long term.

  • National Beverage Corp. (FIZZ) Stock Trends Higher Following Disclosure of Stellar Financial Reports for Q1 2021

    National Beverage Corp. (FIZZ) Stock Trends Higher Following Disclosure of Stellar Financial Reports for Q1 2021

    National Beverage Corp. (FIZZ) stock prices were up by 7.72% some time after market trading commenced on September 10th, 2021. This brought the price per share up to USD$50.40 early on in the trading day.

    Stellar Financial Report

    Net sales for the first quarter of fiscal 2021 were up to USD$311.7 million. Gross profit was reported at USD$128.4 million for the quarter, with gross margin coming in at 40%. FIZZ stock reported operating incoming in the amount of USD$70.3 million, which represented 22.6% of sales for the quarter. Earnings per share improved from USD$0.55 in the prior-year quarter to USD$0.58 in the 2021 quarter. the company reported a very comfortable liquidity position with cash in the amount of USD$245.5 million as of July 31st, 2021. Working capital was reported at USD$269.7 million with a current ratio of 2.8:1.

    Resisting Market Challenges

    Reports for the first quarter of fiscal 2021 reflected stellar execution of the company’s strategy despite headwinds presenting various challenges. Labor, raw material, and transportation availability adversely impacted the company’s ability to meet customer demand. Despite this, the company was able to increase sales over the prior year’s pantry-loading spike at the onset of the global coronavirus pandemic. The company also reported being able to maintain margins that were on par with the prior record-breaking quarter.

    FIZZ Stock’s Consumer Loyalty

    The company’s Power+ brand volume was up by 5.6% for the first quarter of fiscal 2021. The quarter saw selling prices being adjusted to recover higher input and transportation expenses. The company is confident that this reflects the brand loyalty exhibited by consumers, especially in light of the substantial price discounting. This discounting was employed by certain competitors to promote their comparative products.

    FIZZ Stock Expands Product Portfolio

    FIZZ stock launched its unique new LaCroix flavors late last fiscal year. These included Beach Plum, Black Razzberry, and Guava Sao Paulo, which have been the company’s most successful flavors to date. The launches were preceded by successful introductions that consolidate the company’s ability to develop and refine beverages that continue to garner consumer demand.

    Future Outlook for FIZZ Stock

    FIZZ stock reported a promising quarter, as evidenced by the strength of its financial reports for the first quarter of fiscal 2021. The company is keen to allocate resources towards the increased proliferation of its products. Current and potential investors are hopeful that management will be able to facilitate consistent and organic increases in shareholder value over the long term.

  • SOS Stock Surges Following Immense Success of Financial Reports for Q1 2021

    SOS Stock Surges Following Immense Success of Financial Reports for Q1 2021

    SOS Ltd. (SOS) stock prices surged by 18.80% shortly after market trading commenced on September 10th, 2021. This brought the price per share up to USD$3.06 early on in the trading day.

    Net Revenue Reports

    Net revenues for the first half of fiscal 2021 came in at USD$184.5 million. This represented a massive 1700% increase from the numbers reported for the prior year time period. The massive year over year increase demonstrated the strength and effective execution of SOS stock’s business strategy. Rapid market expansion across regional and national markets were the driving forces behind the growth. The company’s addition of cryptomining and commodity trading operations also consolidated the increase. Both of these developments seek to leverage the company’s blockchain expertise.

    Breakdown of Revenues

    SOS stock reported focusing on six product lines and services as of June 30th 2021. These offerings were insurance marketing, telecom call center, bankcard call center, SaaS services, crypto mining, and commodity trading. Insurance marketing comprised 7.23% of the company’s total revenue for first six month period of fiscal 2021. 0.18% was generated from the company’s telecom call center. 0.15% came from bankcard call center, 0.14% from SaaS services, 8.2% from crypto mining operations. By far the most significant contribution of 84.11% came from commodity trading.

    SOS Stock’s Crypto Segment

    The company’s cryptocurrency mining operations began generating revenue from February 2021. SOS stock has reported having mined an aggregate of 132.1 units of BTC and 1,853.1 units of ETH as of June 30th 2021. These units were generated from the company’s mining pools. The figures are comparable to the 42.2 units of BTC and 916.9 units of ETH as of March 31st 2021. This represents a 213% increase in BTC units generated and a 102% increase in the generation of ETH.

    SOS Stock’s Liquidity Position

    SOS stock reported having cash and cash equivalents in the amount of USD$185.5 million as of June 30th 2021. This is comparable to the USD$0.61 million reported as of June 30th 2020. The massive increase was largely driven by the success of the company’s registered direct offerings.

    Future Outlook for SOS Stock

    The first six month period of fiscal 2021 was a transformative time for SOS stock, as evidenced by the strength of its financial reports. The company is keen to continue its trajectory of success on the basis of the momentum generated and the extensive capital raised. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal. This is hoped to facilitate significant and sustained increases in shareholder value.

  • Aviat Networks Inc. (AVNW) Stock Trends Higher as Momentum of Q4 2021 Financial Report Persists

    Aviat Networks Inc. (AVNW) Stock Trends Higher as Momentum of Q4 2021 Financial Report Persists

    Aviat Networks Inc. (AVNW) stock prices were up by 0.17% shortly after market trading commenced on September 10th, 2021. This brought the price per share up to USD$35.71 early on in the trading day.

    AVNW Stock’s Revenue Reports

    Total revenues for the fourth quarter of fiscal 2021 came out to USD$71.7 million. This is comparable to the USD$62.7 million reported in the prior-year quarter, representing a 14.4% or USD$9 million year-over-year increase. AVNW stock’s North American revenues were up by 21.4%, with the 2021 quarter reporting USD$46.4 million compared to the USD$38.2 million in Q4 2020. International revenues were up by 3.5%, coming in at USD$25.3 million for Q4 2021 as compared to the USD$24.4 million reported in the last quarter of 2020.

    Gross Margin Breakdown

    GAAP gross margin for the last quarter of 2021 came out to 36.2%, as compared to the GAAP gross margin of 34.9% as of the prior-year quarter. Non-GAAP gross margin for Q4 2021 came out to 34.9% in Q4 2021. AVNW stock’s year-over-year difference in GAAP gross margin represented an increase of 180 basis points, while non-GAAP gross margin was up by 190 basis points.

    AVNW Stock’s Operating Expenses

    GAAP total operating expenses for Q4 2021 came out to USD$22.1 million. This is comparable to the USD$19.7 million reported in the prior-year quarter, representing an increase of 12.2% or USD$2.4 million. Non-GAAP total operating expenses exclude the effect of AVNW stock’s restructuring charges and share-based compensation. Reports for the fourth quarter of fiscal 2021 came out to USD$20.4 million, up from the USD$17.5 million in Q4 2020. The 16.2 year-over-year increase was largely attributable to the reinvesting of restructuring savings in growth-related initiatives.

    Solid Liquidity Position

    AVNW stock reported a solid liquidity position as of the end of the fourth quarter of fiscal 2021. The company reported USD$47.9 million as of July 2nd, 2021. This is comparable to the USD$45.8 million reported as of April 2nd 2021 and USD$32.6 million as of July 3rd, 2020. The company reported having no outstanding loans at the end of Q4 2021.

    Future Outlook for AVNW Stock

    AVNW stock reported an encouraging end to the fiscal 2021 year, consolidated by the strength of its financial reports for the quarter and the full year. The company is keen to leverage the resources at its disposal to maintain its trajectory of success. Investors are hopeful that this will result in significant and sustained increases in shareholder value.